Healthy Living Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.

Press releases published on April 10, 2026

Apr. 10, 2026

Gene and Cell Therapy Spotlighted in Resurrection LA Premiere May 1–7 as San Rocco Therapeutics Advances Toward a Cure

Indeterminate EIN Presswire

Apr. 10, 2026

San Rocco Productions Announces the Los Angeles Premiere of Resurrection starring JOE MANTEGNA

Indeterminate EIN Presswire

Apr. 10, 2026

Global Cancer Biomarkers Market Surges with Germany at the Core of European Precision Oncology Growth; Roche, QIAGEN

Indeterminate EIN Presswire

Apr. 10, 2026

Global Blood Collection Tube for Liquid Biopsy Market Surges with Europe’s Leadership; QIAGEN N.V., F. Hoffmann-La Roche

Indeterminate EIN Presswire

Apr. 10, 2026

ancora Software Adds 70 New Customers in the First Quarter of 2026, Including 20 New International Customers

Indeterminate EIN Presswire

Apr. 10, 2026

Gentle Patches Claims Evaluated: 2026 Consumer Interest Rises Around Transdermal Wellness Patch Ingredients, Product Lineup, and Policy Transparency

Indeterminate GlobeNewswire

Apr. 10, 2026

Glo & Spa-rkle Aesthetics and Medical Spa Unveils New State-of-the-Art Location in Lubbock, Texas

Indeterminate GlobeNewswire

Apr. 10, 2026

IVY Rx Claims Evaluated: 2026 Compounded GLP-1 Telehealth Program Details, Monthly Pricing Structure, Clinician Access Model, and Patient Eligibility Information

Indeterminate GlobeNewswire

Apr. 10, 2026

ReadyRx NAD+ Rx Claims Evaluated: 2026 Update Highlights Changes in Prescription NAD+ Nasal Spray and Injection Access, Pricing, and Telehealth Eligibility

Indeterminate GlobeNewswire

Apr. 10, 2026

Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma

Indeterminate GlobeNewswire

Apr. 10, 2026

Pelthos Therapeutics Announces CFO Transition

Indeterminate GlobeNewswire

Apr. 10, 2026

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Apr. 10, 2026

Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil® in Duchenne Muscular Dystrophy - CORRECTION

Indeterminate GlobeNewswire

Apr. 10, 2026

Spyre Therapeutics to Host Conference Call to Report SPY001 Part A Induction Topline Results from SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis Patients on April 13, 2026

Indeterminate GlobeNewswire

Apr. 10, 2026

Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Apr. 10, 2026

Allogene Therapeutics to Announce Interim Futility Analysis Data from its Pivotal Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First-Line Consolidation LBCL on Monday, April 13, 2026

Indeterminate GlobeNewswire

Apr. 10, 2026

Busch Group at interpack 2026: Process Safety and Efficiency for Foodstuffs and Pharmaceuticals

Indeterminate EIN Presswire

Apr. 10, 2026

IRADIMED CORPORATION to Participate at the 25th Annual Needham Virtual Healthcare Conference

Indeterminate GlobeNewswire

Apr. 10, 2026

Best Medical Alert Systems 2026: Bay Alarm Medical Awarded Best Medical Alert System

Indeterminate GlobeNewswire

Apr. 10, 2026

Suja Life Announces Filing of Registration Statement for Proposed Initial Public Offering

Indeterminate GlobeNewswire